Cabozantinib to Treat Recurrent Liver Cancer Post Transplant

Clinical trial NCT04204850 · RECRUITING

Trial details

NCT number: NCT04204850
Sponsor: University Health Network, Toronto
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Recurrent Cancer Liver Transplant

Start date: 2020-08-07
Primary completion: 2026-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.